Anavex Life Sciences Corp (AVXL)

[abew4me]

That's simply not true. Try comparing apples with apples.

NVCR is down 65% from their 1-year high of $120. Shares are now at $42...after they reported a successful TLR on June 6th.

AVXL is down 46% from their 1-year high of $15.24. Shares are now at $8.20...after we reported a successful TLR on December 1st.

And note that NVCR had an MC of $13 Billion before they reported their TLR. It is now down to just $4.5 Billion. What happened?

Did their CEO fumble the TLR? NO

Is their CEO dragging his feet with other data? NO

Does the market not trust their CEO because he has no credibility? NO

So, why did their SP drop from $120 to just $42 after they reported a successful TLR?

The same question can be asked of SRPT. They received FDA approval for their drug last Thursday...and yet, their SP has dropped from $160 to just $109. A drop of over 30% in less than a month! What happened to them?

The bottom line is that you can't point the finger at Dr. Missling when the exact same thing is happening to other biotech companies.